Market Tracker

08/22 5:16pm ET

Redhill Biopharma Ltd (NASDAQ:RDHL)

8.89
Delayed Data
As of 3:56pm ET
 +0.04 / +0.45%
Today’s Change
8.16
Today|||52-Week Range
15.83
-15.01%
Year-to-Date

Today’s Trading

Previous close8.85
Today’s open8.90
Day’s range8.83 - 8.99
Volume8,261
Average volume (3 months)68,559
Market cap$151.9M
Dividend yield--
Data as of 3:56pm ET, 08/22/2017

Growth & Valuation

Earnings growth (last year)-21.48%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+3,278.54%
P/E ratio--
Price/Sales1,329.82
Price/Book2.33

Competitors

 Today’s
change
Today’s
% change
ADMPAdamis Pharmaceutica...+0.45+9.28%
SMMTSummit Therapeutics ...+0.37+3.00%
CEMPCempra Inc-0.15-5.26%
CNATConatus Pharmaceutic...+0.03+0.58%
Data as of 4:00pm ET, 08/22/2017

Financials

Next reporting dateNovember 13, 2017
EPS forecast (this quarter)-$0.44
Annual revenue (last year)$101.3K
Annual profit (last year)-$29.5M
Net profit margin-29,079.21%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Dror Ben-Asher
Chief Operating Officer
Gilead Raday
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts